Congress Did Not Intend FDAAA Sec. 912 To Apply To Supplements – Industry
This article was originally published in The Tan Sheet
Executive Summary
FDA should not subject dietary supplements to an FDA Amendment Act of 2007 provision that, if interpreted broadly, would block supplement sales, restrict innovation and discourage pre-market safety and efficacy tests, industry leaders say